CC
PRDS

Cannell Capital’s Pardes Biosciences, Inc. Common Stock PRDS Stock Holding History

Cannell Capital’s Portfolio PRDS Stock Details PRDS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-16,132
Closed -$21.3K – 95
2023
Q1 		$21.3K Hold
16,132
– – ﹤0.01% 86
2022
Q4 		$27.3K Hold
16,132
– – 0.01% 85
2022
Q3 		$30K Buy
16,132
+12,173
+307% +$22.6K 0.01% 88
2022
Q2 		$12K Buy
+3,959
New +$12K ﹤0.01% 72